Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnoldus

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Journal of Autoimmunity|June 30, 2015
Marked variability in clinical presentation and outcome of patients with C1q immunodeficiencyRosanne A van Schaarenburg, Lone Schejbel, Lennart Truedsson, et al.
Disability and Rehabilitation|October 5, 2021
Self-reported work productivity in people with multiple sclerosis and its association with mental and physical healthElianne E A van Egmond, Dennis A M van Gorp, Peter J Jongen, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 20, 2019
Cognitive functioning as a predictor of employment status in relapsing-remitting multiple sclerosis: a 2-year longitudinal studyDennis A M van Gorp, Karin van der Hiele, Marco A P Heerings, et al.
Journal of the Neurological Sciences|July 3, 2021
Self-reported occupational functioning in persons with relapsing-remitting multiple sclerosis: Does personality matter?K van der Hiele, D A M van Gorp, E E A van Egmond, et al.
Multiple Sclerosis and Related Disorders|June 15, 2026
Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosisP C G Molenaar, D L Weir, E P J Arnoldus, et al.
Health and Quality of Life Outcomes|June 3, 2018
The capability set for work - correlates of sustainable employability in workers with multiple sclerosisD A M van Gorp, J J L van der Klink, F I Abma, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 4, 2024
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patientsAlyssa A Toorop, Mark Hj Wessels, Lynn Boonkamp, et al.
Thorax|January 14, 2017
Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activityGabriele Spina, Martijn A Spruit, Jennifer Alison, et al.
BMJ (Clinical Research Ed.)|July 12, 2022
Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysisValentijn M T de Jong, Rebecca Z Rousset, Neftalí Eduardo Antonio-Villa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 25, 2025
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosisLiza M Y Gelissen, Alyssa A Toorop, Pien M Schipper, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Journal of Autoimmunity|June 30, 2015
Marked variability in clinical presentation and outcome of patients with C1q immunodeficiencyRosanne A van Schaarenburg, Lone Schejbel, Lennart Truedsson, et al.
Disability and Rehabilitation|October 5, 2021
Self-reported work productivity in people with multiple sclerosis and its association with mental and physical healthElianne E A van Egmond, Dennis A M van Gorp, Peter J Jongen, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 20, 2019
Cognitive functioning as a predictor of employment status in relapsing-remitting multiple sclerosis: a 2-year longitudinal studyDennis A M van Gorp, Karin van der Hiele, Marco A P Heerings, et al.
Journal of the Neurological Sciences|July 3, 2021
Self-reported occupational functioning in persons with relapsing-remitting multiple sclerosis: Does personality matter?K van der Hiele, D A M van Gorp, E E A van Egmond, et al.
Multiple Sclerosis and Related Disorders|June 15, 2026
Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosisP C G Molenaar, D L Weir, E P J Arnoldus, et al.
Health and Quality of Life Outcomes|June 3, 2018
The capability set for work - correlates of sustainable employability in workers with multiple sclerosisD A M van Gorp, J J L van der Klink, F I Abma, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 4, 2024
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patientsAlyssa A Toorop, Mark Hj Wessels, Lynn Boonkamp, et al.
Thorax|January 14, 2017
Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activityGabriele Spina, Martijn A Spruit, Jennifer Alison, et al.
BMJ (Clinical Research Ed.)|July 12, 2022
Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysisValentijn M T de Jong, Rebecca Z Rousset, Neftalí Eduardo Antonio-Villa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 25, 2025
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosisLiza M Y Gelissen, Alyssa A Toorop, Pien M Schipper, et al.
Pageof 15